FDA Approved: SUMATRIPTAN AND NAPROXEN SODIUM — Original Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved the original ANDA for a generic sumatriptan and naproxen sodium combination tablet for the acute treatment of migraine.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• SUMATRIPTAN AND NAPROXEN SODIUM (Sumatriptan and Naproxen Sodium)

Snippet

ORIG AP for SUMATRIPTAN AND NAPROXEN SODIUM (SUMATRIPTAN AND NAPROXEN SODIUM)